Form 4 for ALNY ALNYLAM PHARMACEUTICALS, INC.
Accepted 2024-06-27 00:00:00 ET · period of report 2024-06-25 · accession 0001735276-24-000072 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-27 | 2024-06-25 | ALNY | SCHULMAN AMY W | Dir | S - Sale+OE | $240.00 | -8,500 | 8,436 | -50% | -$2.04M |
| D | 2024-06-27 | 2024-06-25 | ALNY | SCHULMAN AMY W | Dir | M - OptEx | $131.21 | +8,500 | 16.9K | +101% | +$1.12M |
| D | 2024-06-27 | 2024-06-25 | ALNY | SCHULMAN AMY W | Dir | M - OptEx | $0.00 | -8,500 | 2,750 | -76% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-25 | S | D | 8,500 | $240.00 | 8,436 | D | — | — | |
| 2 | Common | Common Stock | 2024-06-25 | M | A | 8,500 | $131.21 | 16,936 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2024-06-25 | M | D | 8,500 | $0.00 | 2,750 | D | $131.21 · 2016-06-01 to 2025-06-01 | 8,500 Common Stock | (F2) This stock option was fully vested and exercisable as of June 1, 2016. |